This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 5005582

PUBLISHED SUBJECT

BORTEZOMIB 3.5 MG PÓ SOL INJ FR Gemcitabina 40 mg/ml Sol inj Fr 25 ml IV Pemetrexedo 100 mg Pó conc sol inj Fr IV OXALIPLATINA 5 MG/ML SOL INJ FR 40 ML IV DOCETAXEL 20 MG/ML SOL INJ FR 7 ML IV

Parties involved

Place of performance
Portugal, Setúbal, Setúbal
NUTS region
Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
LILLY PORTUGAL-PROD.FARMACEUTICOS, LDA · Tax ID 500165602
Awardee
FRESENIUS KABI PHARMA PORTUGAL,LDA · Tax ID 504293753
Awardee
GENERIS FARMACEUTICA, SA · Tax ID 508107997
Awardee
Janssen Cilag Farmacêutica, Lda · Tax ID 500189412

Values and timeline

Contract price
€42,173.27
Procedure base price
€42,173.27
Total effective price
Not reported on Portal BASE
Publication date
3 December 2018
Award date
27 November 2018
Signing date
27 November 2018
Performance period
10 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Preço ou custo
CPV code
33600000-6 - Produtos farmacêuticos
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
3706810

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts